The Indian healthcare scenario presents a fascinating study of contrasts and opportunities, particularly when analysing the business metrics and strategies of leading hospital chains such as Max Healthcare and Krishna Institute of Medical Sciences (KIMS). The traditional emphasis on Average Revenue Per Occupied Bed (ARPOB) as a key performance indicator reflects a hospital’s ability to
Read more
A recent Study by Alexander V. Eriksen, M.D., and Sören Möller, M.Sc., Ph.D., featured in the New England Journal of Medicine, delves into the capabilities of Generative Pretrained Transformer 4 (GPT-4), a cutting-edge Artificial Intelligence (AI) model, in diagnosing intricate health conditions. Their research arrives as the medical community faces pressing issues: a dwindling number
Read more
The integration of Artificial Intelligence (AI) into the medical science field represents a pivotal moment in healthcare, offering a pathway either toward unprecedented growth and innovation or toward challenges marked by job displacement and economic uncertainties. This juncture requires a thoughtful navigation of AI’s capabilities to amplify the collective potential of the healthcare sector without
Read more
In a landmark deal within the Indian pharmaceutical sector, ERIS Lifesciences has acquired the India-branded formulations business of Biocon Biologics for Rs. 1242 Crore ($150 million), equivalent to 3.4 times the revenue. This acquisition marks ERIS Lifesciences’ entry into the burgeoning $3.6 billion injectables market in India, signifying a pivotal move in its business strategy.
Read more
Most Commented